BTX - Brooklyn Immunotherapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $10.79. This is a potential upside of $4.24 (64.73%) from yesterday's end of day stock price of $6.55.

Brooklyn Immunotherapeutics's activity chart (see below) currently has 2 price targets and 5 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 136 days.

Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 11-Oct-2022. First documented stock forecast 23-Jan-2019.

Best performing analysts who are covering BTX - Brooklyn Immunotherapeutics:

Jason Mccarthy Kristen Kluska

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$5

2 years 6 months 29 days ago
(11-Oct-2022)

1/2 (50%)

$3.65 (270.37%)

272

Buy

$9

$8.79 (4185.71%)

3 years 4 months 10 days ago
(31-Dec-2021)

0/1 (0%)

$4.83 (115.83%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BTX (Brooklyn Immunotherapeutics) average time for price targets to be met?

On average it took 136 days on average for the stock forecasts to be realized with a an average price target met ratio 25

Which analyst has the current highest performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the current lower performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?

KRISTEN KLUSKA

Which analyst has the most public recommendations on BTX (Brooklyn Immunotherapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 2 price targets and 2 ratings on BTX

Which analyst is the currently most bullish on BTX (Brooklyn Immunotherapeutics)?

Kristen Kluska with highest potential upside - $8.79

Which analyst is the currently most reserved on BTX (Brooklyn Immunotherapeutics)?

Jason Mccarthy with lowest potential downside - -$0

Brooklyn Immunotherapeutics in the News

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

NEW YORK, May 01, 2025–(BUSINESS WIRE)–Certain BlackRock closed-end funds (the “Funds”) announced distributions today as detailed below. Municipal Funds: National Funds Ticker Distribution Declaration- 5/1/2025 Ex-Date- 5/15/2025 Record- 5/15/2025 Payable- 6/2/2025 Ticker Distribution Change From Prior Distribution BlackRock Municipal Income Quality Trust* BYM $0.055500 – BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 – BlackRock MuniAssets...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?